PMA

P820075: LAMICEL(TM)

FDA PMA · Dilator, cervical, synthetic, osmotic, pregnancy termination · Medtronic Xomed, Inc.

Key facts

PMA number P820075
Trade name LAMICEL(TM)
Generic name Dilator, cervical, synthetic, osmotic, pregnancy termination
Applicant Medtronic Xomed, Inc.
Owner/operator Medtronic, Inc.
Product code LOB
Approval date Jun 21, 1983
Docket number 83M-0216
Notice date Jul 19, 1983
Establishment registration 1045254
FEI number 1045254

At a glance

  • 1–9 Supplements
  • Jul 16, 1999 Latest supplement decision
  • Yes Withdrawn
  • No Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals